200 related articles for article (PubMed ID: 9153408)
1. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein.
Bosch I; Dunussi-Joannopoulos K; Wu RL; Furlong ST; Croop J
Biochemistry; 1997 May; 36(19):5685-94. PubMed ID: 9153408
[TBL] [Abstract][Full Text] [Related]
2. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.
Pohl A; Lage H; Müller P; Pomorski T; Herrmann A
Biochem J; 2002 Jul; 365(Pt 1):259-68. PubMed ID: 12071854
[TBL] [Abstract][Full Text] [Related]
3. 12-O-tetradecanoylphorbol-13-acetate inhibits aminophospholipid translocase activity and modifies the lateral motions of fluorescent phospholipid analogs in the plasma membrane of bovine aortic endothelial cells.
Julien M; Millot C; Tocanne JF; Tournier JF
Exp Cell Res; 1997 Jul; 234(1):125-31. PubMed ID: 9223377
[TBL] [Abstract][Full Text] [Related]
4. Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein.
Abulrob AG; Gumbleton M
Biochem Biophys Res Commun; 1999 Aug; 262(1):121-6. PubMed ID: 10448079
[TBL] [Abstract][Full Text] [Related]
5. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1).
Dekkers DW; Comfurius P; Schroit AJ; Bevers EM; Zwaal RF
Biochemistry; 1998 Oct; 37(42):14833-7. PubMed ID: 9778357
[TBL] [Abstract][Full Text] [Related]
6. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
7. Differences in the transbilayer and lateral motions of fluorescent analogs of phosphatidylcholine and phosphatidylethanolamine in the apical plasma membrane of bovine aortic endothelial cells.
Julien M; Tournier JF; Tocanne JF
Exp Cell Res; 1993 Oct; 208(2):387-97. PubMed ID: 8375469
[TBL] [Abstract][Full Text] [Related]
8. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
[TBL] [Abstract][Full Text] [Related]
9. Dithionite quenching rate measurement of the inside-outside membrane bilayer distribution of 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled phospholipids.
Angeletti C; Nichols JW
Biochemistry; 1998 Oct; 37(43):15114-9. PubMed ID: 9790674
[TBL] [Abstract][Full Text] [Related]
10. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
11. A non-exchangeable fluorescent phospholipid analog as a membrane traffic marker of the endocytic pathway.
Willem J; ter Beest M; Scherphof G; Hoekstra D
Eur J Cell Biol; 1990 Oct; 53(1):173-84. PubMed ID: 2076704
[TBL] [Abstract][Full Text] [Related]
12. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
[TBL] [Abstract][Full Text] [Related]
14. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
16. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
[TBL] [Abstract][Full Text] [Related]
17. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
Lin JT; Sharma R; Grady JJ; Awasthi S
Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
[TBL] [Abstract][Full Text] [Related]
18. Influence of membrane phospholipid composition and structural organization on spontaneous lipid transfer between membranes.
Pankov R; Markovska T; Antonov P; Ivanova L; Momchilova A
Gen Physiol Biophys; 2006 Sep; 25(3):313-24. PubMed ID: 17197729
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
Chen Y; Pant AC; Simon SM
Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
Bobichon H; Colin M; Depierreux C; Liautaud-Roger F; Jardillier JC
J Exp Ther Oncol; 1996 Jan; 1(1):49-61. PubMed ID: 9414388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
